Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Aug;66(5):1279-1290.
doi: 10.1007/s10840-022-01383-x. Epub 2022 Oct 13.

Racial, ethnic, and sex disparities in atrial fibrillation management: rate and rhythm control

Affiliations
Review

Racial, ethnic, and sex disparities in atrial fibrillation management: rate and rhythm control

Sofia E Gomez et al. J Interv Card Electrophysiol. 2023 Aug.

Abstract

Background: Atrial fibrillation (AF) affects around 6 million Americans. AF management involves pharmacologic therapy and/or interventional procedures to control rate and rhythm, as well as anticoagulation for stroke prevention. Different populations may respond differently to distinct management strategies. This review will describe disparities in rate and rhythm control and their impact on outcomes among women and historically underrepresented racial and/or ethnic groups.

Methods: This is a narrative review exploring the topic of sex and racial and/or ethnic disparities in rate and rhythm management of AF. We describe basic terminology, summarize AF epidemiology, discuss diversity in clinical research, and review landmark clinical trials.

Results: Despite having higher rates of traditional AF risk factors, Black and Hispanic adults have lower risk of AF than non-Hispanic White (NHW) patients, although those with AF experience more severe symptoms and report lower quality-of-life scores than NHW patients with AF. NHW patients receive antiarrhythmic drugs, cardioversions, and invasive therapies more frequently than Black and Hispanic patients. Women have lower rates of AF than men, but experience more severe symptoms, heart failure, stroke, and death after AF diagnosis. Women and people from diverse racial and ethnic backgrounds are inadequately represented in AF trials; prevalence findings may be a result of underdetection.

Conclusion: Race, ethnicity, and gender are social determinants of health that may impact the prevalence, evolution, and management of AF. This impact reflects differences in biology as well as disparities in treatment and representation in clinical trials.

Keywords: Atrial fibrillation; Disparities; Rhythm control.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Minority involvement in atrial fibrillation clinical trials from Sarraju et al. [30]
Fig. 2
Fig. 2
Hazard ratios by sex in CABANA[44] and CASTLE-AF[45] trials showing a non-significant trend toward drug therapy being more favorable among women, with increased outcome variability
Fig. 3
Fig. 3
Racial, ethnic, and sex disparities in AF symptoms, clinical trial data, management (rhythm and rate control), and outcomes

Similar articles

Cited by

References

    1. Schnabel RB, et al. 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study. Lancet. 2015;386(9989):154–62. - PMC - PubMed
    1. Chugh SS, Blackshear JL, Shen WK, Hammill SC, Gersh BJ. Epidemiology and natural history of atrial fibrillation: clinical implications. J Am Coll Cardiol. 2001;37(2):371–8. - PubMed
    1. Flanagin A, Frey T, Christiansen SL, AMA Manual of Style Committee. Updated guidance on the reporting of race and ethnicity in medical and science journals. JAMA. 2021;326(7):621–7. - PubMed
    1. US Census Bureau, “2020 Census statistics highlight local population changes and nation’s racial and ethnic diversity,” Aug. 2021, Accessed: Jan. 09, 2022. [Online]. Available: https://www.census.gov/newsroom/press-releases/2021/population-changes-n...
    1. Cadava G. The Hispanic Republican: the shaping of an American political identity, from Nixon to Trump. HarperCollins, 2020.

Substances